Development and licensing agreement for rHuPH20 (recombinant human hyaluronidase) in development of subcutaneous injectable formulation of recombinant human alpha 1-antitrypsin (rHuA1AT)
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.currentpartnering.com/wp-content/uploads/general/Dealondemandsamples/Sample%20deal%20on%20demand.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (4)
Alternatively, you can try searching for similar contracts:
